Full Text View
Tabular View
No Study Results Posted
Related Studies
Spironolactone in Diabetic Nephropathy
This study has been completed.
Study NCT00317954   Information provided by Steno Diabetes Center
First Received: April 21, 2006   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetic Nephropathy
Additional conditions recognized in this trial
Diabetic Nephropathies
Kidney Diseases
More general conditions related to this trial
Diabetes Complications
Diabetes Mellitus
Endocrine System Diseases
Urologic Diseases
Interventions listed in this trial
Spironolactone
More general drug interventions related to this trial
Aldosterone Antagonists
Cardiovascular Agents
Diuretics
Hormone Antagonists
Hormones, Hormone Substitutes, and Hormone Antagonists
Natriuretic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Steno Diabetes Center


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services